InvestSMART

ImpediMed Limited (ASX: IPD) - Announcements

Current share price for IPD : $0.004 0.001 (11.11%)+

ASX company news and announcements for ImpediMed Limited (IPD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ImpediMed Limited (IPD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ImpediMed Limited (IPD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ImpediMed Limited (IPD)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$15 Becoming a substantial holder from AEF 22 Jan 2020 5:18PM $0.135 $0.004 fallen by 97.04%
$15 Appendix 4C - Quarter ended 31 December 2019 22 Jan 2020 8:27AM $0.170 $0.004 fallen by 97.65%
$15 ImpediMed Quarterly Results and Investor Conference Call 17 Jan 2020 8:24AM $0.170 $0.004 fallen by 97.65%
$15 Change of Director's Interest Notice - Don Williams 7 Jan 2020 8:32AM $0.160 $0.004 fallen by 97.50%
$15 Change of Director's Interest Notice - Scott Ward 7 Jan 2020 8:32AM $0.160 $0.004 fallen by 97.50%
$15 Change of Director's Interest Notice - Amit Patel 7 Jan 2020 8:31AM $0.160 $0.004 fallen by 97.50%
$15 Change of Director's Interest Notice - Dr Robert Graham 7 Jan 2020 8:31AM $0.160 $0.004 fallen by 97.50%
$15 Change of Director's Interest Notice - Gary Goetzke 7 Jan 2020 8:30AM $0.160 $0.004 fallen by 97.50%
$15 Change of Director's Interest Notice - Judith Downes 7 Jan 2020 8:30AM $0.160 $0.004 fallen by 97.50%
$15 Change of Director's Interest Notice - Richard Carreon 7 Jan 2020 8:29AM $0.160 $0.004 fallen by 97.50%
$15 Appendix 3B 7 Jan 2020 8:25AM $0.160 $0.004 fallen by 97.50%
$15 Appendix 3B 3 Jan 2020 8:19AM $0.155 $0.004 fallen by 97.42%
$15 FDA 510(k) Clearance-Protein Calorie Malnutrition Assessment 28 Nov 2019 8:24AM $0.180 $0.004 fallen by 97.78%
$15 Change of Director's Interest Notice - Don Williams 19 Nov 2019 10:52AM $0.210 $0.004 fallen by 98.10%
$15 Change of Director's Interest Notice - Scott Ward 19 Nov 2019 10:50AM $0.210 $0.004 fallen by 98.10%
$15 Change of Director's Interest Notice - Amit Patel 18 Nov 2019 4:10PM $0.210 $0.004 fallen by 98.10%
$15 Change of Director's Interest Notice - Gary Goetzke 18 Nov 2019 4:09PM $0.210 $0.004 fallen by 98.10%
$15 Change of Director's Interest Notice - Dr Robert Graham 18 Nov 2019 4:04PM $0.210 $0.004 fallen by 98.10%
$15 Change of Director's Interest Notice - Judith Downes 18 Nov 2019 4:03PM $0.210 $0.004 fallen by 98.10%
$15 Change of Director's Interest Notice - Richard Carreon 18 Nov 2019 4:01PM $0.210 $0.004 fallen by 98.10%
$15 Notice under Section 708A(5)(e) of the Corporations Act 14 Nov 2019 7:52PM $0.190 $0.004 fallen by 97.89%
$15 Appendix 3B 14 Nov 2019 7:49PM $0.190 $0.004 fallen by 97.89%
$15 Appendix 3B 14 Nov 2019 8:28AM $0.165 $0.004 fallen by 97.58%
$15 Appendix 3B 13 Nov 2019 8:26AM $0.160 $0.004 fallen by 97.50%
$15 Amendment to Constitution 12 Nov 2019 2:48PM $0.150 $0.004 fallen by 97.33%

701 - 725 of 1217 results

Page 29 of 49

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.